2269:HKG
WuXi Biologics (Cayman) Inc
HK$48.20
arrow_downward
-0.90%(-0.44) 1D
වප් 16, 16.08.14 ග්‍රිමවේ+8 · HKD
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_auto2269 සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
HK$49.98
ඉහළ
HK$50.85
පහළ
HK$45.82
වෙ.පො ප්‍රාග්ධනය
බි198.43
දළ පරිමාව
මි30.42
හඬ පරිමාණය
මි55.18
P/E අනුපාතය
34.48
සති-52 ඉහළ
HK$58.00
සති-52 පහළ
HK$28.48
EPS
HK$1.40
ගෙවිය යුතු කොටස්
බි1.23
සේවකයින් ගණන
ද15
විවෘත කරන්න
HK$49.98
ඉහළ
HK$50.85
පහළ
HK$45.82
වෙ.පො ප්‍රාග්ධනය
බි198.43
දළ පරිමාව
මි30.42
හඬ පරිමාණය
මි55.18
P/E අනුපාතය
34.48
සති-52 ඉහළ
HK$58.00
සති-52 පහළ
HK$28.48
EPS
HK$1.40
ගෙවිය යුතු කොටස්
බි1.23
සේවකයින් ගණන
ද15
පුවත් සහ කථා
වෙබ් මූලාශ්‍ර සහ ප්‍රවෘත්ති හවුල්කරුවන්ගෙන්
Simply Wall Street
·
මිනිත්තු 30කට පෙර
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
Law360
·
පැය 1කට පෙර
Nasdaq Sued Over Delisting Of Social Media Co.
Kalkine Media
·
මිනිත්තු 40කට පෙර
Royal Bank of Canada Launches Bearish PLUS Securities on S&P 500 with Maturity in November 2027
Yahoo Finance
·
පැය 1කට පෙර
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
පැතිකඩ
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
WuXi Biologics (Cayman) Inc ගැන